Zealand Pharma A/S (CPH:ZEAL)

Zealand Pharma Ratios and Metrics

Market cap in millions DKK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43,097	50,548	21,785	10,366	6,271	8,766
Market Cap Growth	132.03%	132.03%	110.16%	65.31%	-28.46%	3.46%
Enterprise Value	34,443	41,733	20,319	10,519	5,364	7,371
Last Close Price	610.00	715.50	373.20	201.40	145.10	220.60
PS Ratio	806.30	806.30	63.55	99.69	57.77	45.65
PB Ratio	5.00	5.87	13.68	12.70	6.76	7.13
P/TBV Ratio	5.87	5.87	13.78	12.70	7.17	7.48
EV/Sales Ratio	665.70	665.70	59.28	101.16	49.41	38.39
EV/FCF Ratio	-36.61	-	-	-	-	-
Debt / Equity Ratio	0.05	0.05	0.07	0.64	0.85	0.11
Asset Turnover	0.01	0.01	0.19	0.06	0.06	0.11
Inventory Turnover	0.85	0.85	0.69	-	0.12	-
Quick Ratio	21.11	21.11	6.23	6.73	4.80	3.71
Current Ratio	21.14	21.14	6.25	6.73	5.15	4.00
Return on Equity (ROE)	-21.13%	-21.13%	-58.43%	-110.75%	-70.00%	-54.10%
Return on Assets (ROA)	-13.81%	-13.81%	-19.93%	-28.30%	-25.53%	-23.29%
Return on Capital (ROIC)	-14.80%	-14.80%	-22.99%	-33.41%	-31.80%	-29.12%
Earnings Yield	-2.50%	-2.13%	-3.23%	-11.60%	-16.24%	-9.66%
FCF Yield	-2.18%	-1.86%	-2.01%	-9.20%	-19.68%	-8.14%
Buyback Yield / Dilution	-17.40%	-17.40%	-22.49%	-7.77%	-11.73%	-13.51%
Total Shareholder Return	-17.40%	-17.40%	-22.49%	-7.77%	-11.73%	-13.51%

Source: S&P Capital IQ. Standard template. Financial Sources.